Donaldson Company Reports 3.9% Net Sales Increase and 15.1% Rise in Net Earnings for Quarter Ended October 31, 2025

Donaldson Company, Inc. reported a net sales increase of 3.9% for the three months ended October 31, 2025, reaching $935.4 million compared to $900.1 million in the same period last year. The company's net earnings also rose to $113.9 million, a 15.1% increase from $99.0 million in the prior year, resulting in diluted earnings per share of $0.97, up from $0.81. The growth in revenue was primarily driven by a 4.5% increase in the Mobile Solutions segment, which generated $598.3 million, and a 13.1% increase in the Life Sciences segment, which reached $79.3 million. The Industrial Solutions segment remained relatively stable, with a slight increase to $257.8 million.

In terms of operational changes, Donaldson's cash flow from operating activities significantly improved, totaling $125.4 million for the quarter, compared to $72.9 million in the previous year. This increase was attributed to a decrease in working capital requirements. The company also reported a reduction in cash used in investing activities, which fell to $3.4 million from $96.0 million, largely due to the absence of significant equity investments compared to the previous year. However, cash used in financing activities increased to $93.1 million, primarily due to higher share repurchases, which totaled $91.5 million during the quarter.

Donaldson's balance sheet showed total assets of $3.03 billion as of October 31, 2025, up from $2.98 billion at the end of the previous fiscal year. The company’s cash and cash equivalents increased to $210.7 million, while total liabilities decreased to $1.51 billion from $1.52 billion. The company’s long-term debt rose to $678.0 million, reflecting ongoing share repurchase activities. Donaldson maintained compliance with its financial covenants and reported a total debt to capitalization ratio of 31.0%.

Strategically, Donaldson continues to focus on optimizing its operational footprint and enhancing its product offerings. The company has been actively managing its costs and has implemented restructuring initiatives that resulted in a restructuring expense of $3.4 million for the quarter. Additionally, Donaldson's investment in Medica, a leader in hollow fiber membrane filtration technology, remains a key strategic move, although its financial impact was not material in the current quarter. Looking ahead, the company anticipates continued growth driven by pricing benefits, favorable foreign currency impacts, and volume growth across its segments, while also navigating potential challenges from global economic conditions and trade policies.